author-photo

Ramakumar Tummala

University of California, Davis

31

Papers

812

Citations

Citation Trend

Filter By

Papers (19) Sort By

Journal Conference Others

Quercetin Targets hnRNPA1 to Overcome Enzalutamide Resistance in Prostate Cancer Cells

2017 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (50)
Lin28 induces resistance to anti-androgens via promotion of AR splice variant generation.

2016 The Prostate
Show All
- Source
- Cite
- Save
Citations (18)
NF-κB2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate Cancer.

2015 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (76)
MP46-03 NF-KAPPAB2/P52:C-MYC:HNRNPA1 REGULATORY PATHWAY CONTROLS EXPRESSION OF ANDROGEN RECEPTOR SPLICE VARIANTS AND ENZALUTAMIDE SENSITIVITY IN PROSTATE CANCER

2015 The Journal of Urology
Show All
- Source
- Cite
- Save
Citations (10)
MP24-07 NF-KAPPAB2/P52 INDUCES RESISTANCE TO ENZALUTAMIDE IN PROSTATE CANCER: ROLE OF ANDROGEN RECEPTOR AND ITS VARIANTS

2014 The Journal of Urology
Show All
- Source
- Cite
- Save
Citations (27)
RhoGDIα downregulates androgen receptor signaling in prostate cancer cells

2013 The Prostate
Show All
- Source
- Cite
- Save
Citations (3)
Abstract 100: NF-κB2/p52 induces resistance to enzalutamide possibly by upregulation of AR-V7.

2013 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Inhibition of ABCB1 Expression Overcomes Acquired Docetaxel Resistance in Prostate Cancer

2013 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (74)
975 MIR-LET-7C AXIS REGULATES ANDROGEN SIGNALING AND THE GROWTH OF PROSTATE CANCER CELLS

2013 The Journal of Urology
Show All
- Source
- Cite
- Save
Citations (0)
NF-κB2/p52 Induces Resistance to Enzalutamide in Prostate Cancer: Role of Androgen Receptor and Its Variants

2013 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (138)